Skip to main content

Table 1 Tumor inhibition rate of 131 I-hVEGF siRNA/SilenceMag 28 days post treatment

From: Superparamagnetic iron oxide nanoparticles mediated 131I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice

Group

Tumor weight (mg)

Tumor inhibition rate (%)

 

( x ¯ ±s)

 

131I-hVEGF siRNA/SilenceMag + EMF

460.10±29.50

49.80±3.25

(Z=1.96, P=0.05)*

131I-hVEGF siRNA/SilenceMag

978.20±19.90

-6.70±2.20

(Z=1.09, P=0.26)*

(Z=1.96, P=0.05)#

hVEGF siRNA/SilenceMag + EMF

499.70±7.60

48.10±5.30

(Z=1.96, P=0.05)*

(Z=0.66, P=0.51)#

Control

916.60±91.20

―

  1. Z-Value was placed within bracket. *Compared with control. #Compared with the first group (131I-hVEGF siRNA/SilenceMag + EMF).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us